# A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab

> **NCT07520162** · PHASE3 · NOT_YET_RECRUITING · sponsor: **AstraZeneca** · enrollment: 230 (estimated)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyps

## Interventions

- **DRUG:** Tezepelumab

## Key facts

- **NCT ID:** NCT07520162
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-06
- **Primary completion:** 2028-03-07
- **Final completion:** 2028-08-15
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07520162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07520162, "A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07520162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*